live
viral
vector
express
foreign
antigen
shown
great
promis
vaccin
viral
diseas
howev
safeti
concern
remain
major
problem
regard
use
even
highli
attenu
viral
vector
use
rabi
viru
rv
envelop
protein
carrier
molecul
show
inactiv
rv
particl
util
present
bacillu
anthraci
protect
antigen
pa
viral
membran
addit
rv
glycoprotein
g
transmembran
cytoplasm
domain
portion
rv
g
ectodomain
requir
express
chimer
rv
g
anthrax
pa
cell
surfac
novel
antigen
also
effici
incorpor
rv
virion
mice
immun
inactiv
recombin
rv
virion
exhibit
seroconvers
rv
g
anthrax
pa
second
inocul
greatli
increas
respons
data
demonstr
viral
envelop
protein
carri
bacteri
protein
viral
carrier
display
whole
polypeptid
compar
limit
epitop
present
previou
viral
system
recent
infect
bacillu
anthraci
caus
agent
anthrax
pose
low
risk
minim
natur
occurr
human
howev
develop
b
anthraci
bioterror
tool
death
five
peopl
infect
least
seventeen
other
us
jernigan
et
al
underscor
danger
anthrax
attack
exist
prophylact
therapeut
strategi
combat
anthrax
insuffici
lethal
form
diseas
inhal
anthrax
present
gener
flulik
symptom
earli
diagnosi
difficult
prompt
recognit
symptom
requir
effect
therapeut
treatment
use
antibiot
passiv
immun
follow
unknown
exposur
sternbach
passiv
immun
effect
sawadahirai
et
al
avail
immun
sera
highli
limit
approv
therapeut
antibodi
anthrax
current
avail
sever
antibiot
care
effect
b
anthraci
antimicrobi
resist
engin
futur
bioterrorismgrad
anthrax
envis
moreov
antibiot
elimin
bacteria
toxin
may
alreadi
releas
thu
vaccin
highli
practic
altern
postexposur
treatment
elimin
risk
infect
virolog
wwwelseviercomlocateyviro
anthrax
diseas
caus
toxin
anthrax
toxin
act
tripartit
system
transport
activ
compon
lethal
edema
factor
cell
facilit
bind
compon
protect
antigen
pa
pa
bind
receptor
cell
surfac
cleav
cellular
furin
molloy
et
al
small
subunit
larger
constitu
seven
receptorbound
unit
oligomer
form
complex
bind
lethal
factor
edema
factor
pass
cytoplasm
two
receptor
bradley
et
al
scobi
et
al
bind
pa
mediat
toxic
pa
compris
four
distinct
domain
receptor
interact
occur
site
within
pa
structur
receptor
bind
ridg
highli
conserv
suggest
interact
pa
manner
santelli
et
al
passiv
activ
immun
indic
protect
mediat
humor
immun
respons
enserink
pitt
et
al
welko
et
al
bind
pa
cell
surfac
receptor
prevent
antipa
antibodi
note
antibodi
elicit
pa
immun
confer
protect
b
anthraci
challeng
beedham
et
al
ivin
et
al
ivin
et
al
kobil
et
al
littl
et
al
antibodi
epitop
within
pa
also
show
protect
capac
flicksmith
et
al
kasuya
et
al
maynard
et
al
fdalicens
vaccin
anthrax
exist
consist
cell
cultur
filtrat
adsorb
onto
aluminum
hydroxid
bioport
howev
sever
aspect
product
point
need
develop
novel
vaccin
indic
use
atrisk
individu
ii
materi
difficult
character
turnbul
iii
requir
six
immun
within
first
year
annual
booster
thereaft
bioport
iv
reactogen
report
patient
bioport
addit
vaccin
strategi
focu
pa
pursu
includ
dna
vaccin
encod
pa
ferrari
et
al
well
approach
use
variou
microorgan
vector
express
pa
influenza
li
et
al
vaccinia
viru
iaconoconnor
et
al
adenoviru
tan
et
al
venezuelan
equin
enceph
virusbas
replicon
lee
et
al
salmonella
enterica
serovar
typhimurium
live
vaccin
encod
domain
four
pa
galen
et
al
bestdevelop
vaccin
candid
recombin
pa
rpa
adsorb
aluminum
hydroxid
keyserl
et
al
effort
enhanc
immunogen
rpa
includ
immunogen
formul
copolym
coeshott
et
al
microspher
encapsul
flicksmith
et
al
addit
adjuv
berthold
et
al
ivin
et
al
ivin
et
al
mcbride
et
al
rabi
viru
promis
vaccin
vector
abl
induc
humor
cellular
immun
respons
effici
foreign
antigen
mcgettigan
et
al
mcgettigan
et
al
schnell
et
al
low
seropreval
human
popul
rv
excel
viral
vector
candid
method
engin
viru
well
establish
two
foreign
gene
total
kb
incorpor
thu
far
foreign
sequenc
stabli
maintain
rv
grow
high
titer
cell
line
approv
human
vaccin
product
manufactur
econom
current
rv
vaccin
vector
base
vaccin
strain
use
sinc
live
oral
immunogen
vaccin
wild
life
europ
asia
schneider
et
al
increas
safeti
sever
attenu
mutat
introduc
live
viral
vector
mckenna
et
al
inactiv
rv
use
vaccin
human
u
sinc
plotkin
thu
signific
histori
safeti
haupt
potent
longlast
neutral
antibodi
rv
glycoprotein
gener
immun
kill
particl
thraenhart
et
al
strong
humor
respons
heterolog
glycoprotein
envelop
mckenna
et
al
schnell
et
al
hcv
siler
et
al
elicit
kill
rv
particl
incorpor
foreign
protein
highli
repetit
rigid
organ
virus
viruslik
particl
thought
maxim
stimul
b
cell
fehr
et
al
jegerlehn
et
al
helper
epitop
provid
viru
particl
also
provid
necessari
signal
b
cell
activ
hooper
et
al
gener
sever
rv
gpa
chimera
either
pa
fuse
ectodomain
ed
truncat
mutant
rv
g
one
chimera
properli
traffick
cell
surfac
effici
incorpor
viru
particl
mice
immun
kill
particl
mount
high
antibodi
titer
b
anthraci
pa
respons
dosedepend
skew
toward
antibodi
lymphocyt
prolifer
also
observ
respons
viral
antigen
anthrax
pa
result
suggest
inactiv
rabi
viru
serv
immunostimulatori
carrier
immun
pathogen
anthrax
anthrax
pa
excel
target
anthrax
vaccin
particular
antipa
antibodi
prevent
entri
toxin
cell
therefor
anthrax
optim
human
codon
usag
ensur
high
express
level
clone
rv
vaccin
vector
pspbn
result
fig
recombin
rv
recov
standard
method
express
confirm
immunostain
antipa
monoclon
antibodi
fig
panel
analyz
immunogen
recombin
rv
five
balbc
mice
inocul
im
ffu
sera
immun
mice
analyz
paspecif
elisa
day
immun
howev
paspecif
antibodi
detect
immun
anim
data
shown
determin
whether
surfac
express
anthrax
pa
might
increas
immunogen
vaccin
host
use
rv
g
er
transloc
ss
addit
rv
g
tm
cd
fig
gene
encod
chimer
rv
ganthrax
pa
introduc
rv
vector
pspbn
result
bsr
cell
infect
spbn
fig
antibodi
direct
pa
fig
panel
permeabil
triton
intern
stain
antibodi
anthrax
pa
fig
panel
rv
n
protein
fig
panel
b
c
cell
infect
rv
indic
bright
signal
rv
nspecif
antibodi
moreov
antipa
monoclon
antibodi
detect
intern
express
cell
howev
express
cell
surfac
detect
either
virus
express
independ
use
rv
g
signal
sequenc
test
hypothesi
lack
transport
er
golgi
apparatu
account
lack
surfac
express
portion
rv
g
might
support
transport
util
differ
portion
rv
g
ed
addit
tm
cd
rv
g
construct
five
differ
plasmid
contain
increas
portion
rv
g
ed
addit
anthrax
pa
base
previou
research
indic
anthrax
pa
potent
antigen
induc
protect
antibodi
use
fragment
compris
carboxytermin
region
pa
use
fragment
allow
us
examin
whether
flank
rv
g
ss
tm
cd
fail
transport
cell
surfac
observ
gene
encod
rv
ganthrax
pa
fusion
protein
contain
amino
acid
rv
ed
pcramplifi
introduc
express
plasmid
control
rna
polymeras
promotor
fig
result
plasmid
design
evalu
cell
surfac
express
recombin
rv
fusion
protein
bsr
cell
infect
recombin
vaccinia
viru
express
rna
polymeras
one
h
transfect
five
plasmid
h
later
fix
paraformaldehyd
permeabil
immunostain
antipa
monoclon
antibodi
second
set
transfect
cell
treat
similarli
permeabil
shown
fig
protein
success
express
intern
stain
transfect
cell
wherea
signific
surfac
express
detect
recombin
protein
surfac
stain
quantit
analysi
fac
fig
confirm
express
high
level
cell
surfac
surfac
express
detect
lower
level
observ
western
blot
analysi
transfect
cell
lysat
use
antibodi
direct
anthrax
pa
rv
g
cd
fig
reveal
chimer
rv
protein
expect
size
kda
kda
kda
kda
paand
rv
g
cdspecif
antibodi
interestingli
rv
g
cddirect
antibodi
fail
detect
fusion
protein
suggest
cleavag
degrad
carboxyterminu
protein
antibodi
direct
aminoterminalloc
detect
protein
smaller
predict
size
indic
degrad
recombin
fusion
protein
show
diffus
migrat
pattern
rang
kda
sequenc
analysi
pa
indic
sever
potenti
nand
oglycosyl
site
within
might
contribut
observ
retard
migrat
fig
construct
plasmid
contain
fuse
variou
rv
g
ed
fragment
panel
show
rv
g
protein
shown
panel
three
potenti
site
nlink
glycosyl
indic
construct
chimer
rv
ganthrax
pa
fusion
protein
rv
g
ed
replac
domain
pa
b
membraneproxim
amino
acid
rv
g
ectodomain
contain
one
two
three
potenti
nlink
glycosyl
site
respect
reintroduc
gener
respect
c
e
fulllength
rv
g
ectodomain
insert
result
f
result
indic
highest
level
surfac
express
suggest
suitabl
incorpor
rv
envelop
thu
gene
encod
clone
pspbn
result
recombin
expect
rv
g
cdspecif
antibodi
detect
rv
g
virus
addit
protein
migrat
expect
size
detect
case
cell
virion
fig
lane
success
incorpor
virion
enabl
us
studi
induct
antipa
immun
respons
use
inactiv
live
anim
model
three
group
five
femal
swiss
webster
mice
inocul
im
ffu
inact
ffu
spbn
inact
spbn
blood
sampl
obtain
mice
day
postimmun
sera
analyz
elisa
plate
coat
rpa
rv
g
shown
fig
immun
mice
seroconvert
rv
g
moreov
mice
prime
inactiv
live
also
mount
anthrax
paspecif
antibodi
detect
sera
mice
immun
spbn
second
inocul
increas
rv
gspecif
titer
wherea
anthrax
paspecif
elisa
titer
increas
signific
differ
antibodi
titer
mice
immun
live
rv
inactiv
rv
virion
fig
sever
vaccin
approach
appear
promis
mice
difficult
reproduc
larger
anim
human
due
larg
amount
antigen
need
immun
thu
perform
doserespons
analysi
use
antigen
amount
fig
express
incorpor
rv
particl
bsr
cell
infect
spbn
moi
h
cell
lysat
prepar
separ
sdspage
transfer
nitrocellulos
membran
lane
analyz
incorpor
rv
virion
sucrosepurifi
spbn
particl
separ
sdspage
transfer
nitrocellulos
membran
lane
blot
probe
either
sera
direct
rv
g
cd
antipa
monoclon
antibodi
analyz
surfac
express
fusion
protein
transfect
cell
fix
paraformaldehyd
either
permeabil
intern
stain
triton
left
untreat
surfac
stain
cell
stain
mous
antipa
monoclon
antibodi
follow
fitclabel
donkey
antimous
examin
fluoresc
microscopi
fac
analysi
transfect
cell
stain
mous
antipa
follow
fitclabel
donkey
antimous
fix
formaldehyd
analyz
flow
cytometri
b
western
blot
analysi
lysat
transfect
cell
prepar
separ
sdspage
transfer
nitrocellulos
membran
blot
probe
either
sera
direct
rv
g
cd
right
panel
antipa
monoclon
antibodi
left
panel
rang
ng
mixtur
ng
recombin
pa
ng
rv
g
includ
control
group
three
mice
immun
respect
antigen
day
bled
day
postimmun
sera
analyz
rv
gand
anthrax
paspecif
elisa
tabl
mice
immun
kill
rang
ng
show
strong
respons
rv
g
anthrax
pa
moreov
immun
littl
ng
result
antigenspecif
seroconvers
respons
immun
rpa
rv
g
mice
mount
titer
similar
ng
dose
second
inocul
vaccin
use
prime
significantli
increas
pa
rv
g
respons
addit
antibodi
level
sera
mice
immun
twice
recombin
pa
rv
g
compar
sera
mice
immun
twice
ng
separ
experi
experi
b
tabl
use
antigen
schedul
increas
amount
recombin
anthrax
pa
rv
g
show
similar
result
except
increas
amount
rv
g
protein
induc
higher
antigenspecif
seroconvers
howev
prime
ng
pa
still
result
low
paspecif
titer
prime
determin
whether
differ
igg
subclass
induc
immun
approach
sera
doserespons
immun
regimen
use
experi
b
analyz
paspecif
elisa
shown
fig
immun
kill
particl
elicit
predominantli
wherea
immun
protein
result
high
level
compar
although
cell
known
facilit
antibodi
product
remain
whether
cell
underli
potent
seroconvers
prime
inactiv
virion
antigenspecif
prolif
respons
immun
analyz
memori
immun
respons
elicit
vaccin
novel
vaccin
carrier
spleen
four
swiss
webster
mice
either
left
unimmun
fig
open
bar
immun
im
inactiv
fig
shade
bar
day
harvest
week
postboost
splenocyt
stimul
rv
g
rv
rnp
inactiv
virion
spbn
recombin
pa
see
materi
method
three
four
immun
mice
prolif
respons
greatli
increas
restimul
rvspecif
antigen
wherea
one
mous
mount
detect
respons
comparison
two
group
show
respons
differ
restimul
inactiv
rv
particl
p
rv
rnp
p
immun
group
also
respond
rv
g
p
note
substanti
prolif
respons
p
detect
restimul
recombin
anthrax
pa
indic
respons
also
occur
absenc
rv
antigen
report
describ
develop
novel
approach
creat
potenti
vaccin
anthrax
use
inactiv
rv
carrier
viru
particl
present
surfac
antigen
dens
repetit
array
maxim
stimul
b
cell
prolifer
antibodi
product
zinkernagel
addit
viru
particl
provid
helper
epitop
suppli
requir
second
signal
b
cell
activ
baumgarth
incorpor
properti
vaccin
anthrax
gener
rv
particl
display
two
independ
experi
b
perform
experi
group
three
mice
immun
im
ng
ng
ng
inactiv
ng
rv
g
ng
rpa
day
mice
bled
week
immun
sera
group
pool
place
triplic
elisa
well
geometr
mean
determin
experi
b
mice
immun
bled
experi
except
protein
group
immun
ng
rv
g
ng
rpa
sera
individu
mice
run
elisa
geometr
mean
determin
three
mice
yield
titer
antigen
compon
b
anthraci
engin
rv
g
pa
express
surfac
rv
particl
viru
particl
express
chimera
heterolog
glycoprotein
produc
gener
virus
express
viral
glycoproteinbacteri
toxin
fusion
protein
recent
exemplifi
insert
pa
influenza
viru
hemagglutinin
li
et
al
rv
g
type
transmembran
protein
exist
viru
particl
homotrim
gaudin
et
al
glycoprotein
rv
vesicular
stomat
viru
vsv
close
relat
rhabovirus
share
amino
acid
homolog
ectodomain
predict
similar
threedimension
structur
whitt
et
al
studi
tabl
evalu
antianthraxpaspecif
respons
elisa
seroconvers
detect
ng
dose
prime
spbn
sera
analyz
na
vsv
demonstr
requir
trimer
format
endoplasm
reticulum
transport
vsv
g
cell
surfac
dom
et
al
dom
et
al
consist
observ
initi
construct
patc
well
lack
rv
g
ectodomain
transport
cell
surfac
addit
shown
glycosyl
least
one
site
rv
g
ectodomain
requir
trimer
format
cellsurfac
express
wildtyp
rv
g
shakineshleman
et
al
vsv
g
membran
proxim
amino
acid
ed
requir
trimer
format
cell
surfac
express
subsequ
viru
incorpor
robison
whitt
howev
explain
rv
g
chimera
success
traffick
cell
surfac
region
rv
g
ed
contain
potenti
glycosyl
site
howev
trimer
molecul
wild
type
rv
g
might
also
requir
transport
possibl
await
biochem
analys
succeed
express
chimer
rv
ganthrax
pa
fusion
protein
cell
surfac
concern
remain
regard
transport
chimer
glycoprotein
depend
size
foreign
polypeptid
howev
preliminari
result
use
entir
aa
well
heavychain
botulinum
neurotoxin
aa
fuse
construct
indic
excel
cell
surfac
express
koser
schnell
unpublish
togeth
result
show
rv
g
permiss
fusion
larg
foreign
protein
fragment
viru
particl
incorpor
chimer
glycoprotein
rvbase
vector
replicationcompet
well
accept
pa
major
antigen
compon
current
anthrax
vaccin
bioport
anthrax
vaccin
develop
focu
pa
lack
humor
respons
initi
vaccin
express
live
rv
entir
surpris
sinc
protein
produc
intracellularli
avail
stimul
b
cell
therefor
probabl
low
previous
report
nucleoprotein
sarscov
immunogen
mice
express
similar
rv
vaccin
vector
high
titer
neutral
antibodi
detect
sarscov
spike
protein
express
rv
faber
et
al
even
though
reason
might
lie
differ
immunogen
two
sarscov
protein
appear
protein
express
cell
surfac
incorpor
rv
virion
potent
induc
humor
respons
intern
express
protein
motion
support
find
singl
immun
rv
induc
strong
humor
respons
rv
g
modest
respons
intern
rv
protein
contrast
pa
express
surfac
viru
particl
induc
potent
humor
respons
either
live
kill
particl
stimul
antibodi
product
singl
dose
note
sever
approach
anthrax
vaccin
requir
multipl
dose
induct
antibodi
respons
auling
et
al
galen
et
al
rhie
et
al
consist
expect
particl
maxim
stimul
b
cell
rv
g
wild
type
viru
compris
viru
mass
flamand
et
al
wunner
chimer
glycoprotein
incorpor
best
equival
rv
g
thu
attribut
viru
particl
mass
glycoprotein
dose
contain
antigen
dose
equival
ng
rpa
specul
decreas
dose
requir
due
present
viru
particl
consist
studi
compar
immunogen
protein
present
solubl
form
disord
form
versu
protein
complex
virus
viruslik
particl
eckhart
et
al
fehr
et
al
fehr
et
al
addit
maxim
stimul
b
cell
upon
prime
viru
particl
expect
strong
induc
cell
help
especi
compar
monomer
recombin
protein
rv
g
nucleocapsid
possess
helper
epitop
bunschoten
et
al
ertl
et
al
macfarlan
et
al
exposur
mice
rv
ribonucleoprotein
significantli
augment
virusneutr
antibodi
upon
subsequ
introduct
rv
hooper
et
al
anthrax
immun
pa
antibodysubstimul
level
prime
robust
rapid
humor
respons
upon
boost
compar
without
prime
marcu
et
al
expect
boost
second
dose
live
kill
result
increas
antipa
antirv
g
titer
high
antibodi
titer
also
result
follow
boost
rpa
clear
differ
igg
subclass
antibodi
pa
either
induc
vaccin
passiv
administ
confer
protect
challeng
beedham
et
al
ivin
et
al
stimul
type
respons
desir
analog
case
ava
semenova
et
al
rpa
formul
aluminum
hydroxid
tan
et
al
subclass
distribut
sera
mice
immun
ng
primarili
indic
respons
contrast
ng
dose
well
rpa
stimul
antibodi
consist
notion
igg
subclass
respons
depend
upon
dose
context
antigen
present
demonstr
kill
rv
particl
serv
immunostimulatori
carrier
molecul
display
foreign
b
cell
antigen
recombin
particl
potent
induc
humor
immun
respons
even
singl
inocul
might
especi
import
preexposur
treatment
rapid
respons
requir
observ
immun
respons
immun
mice
show
potent
memori
respons
result
establish
proofofconcept
design
particl
abil
stimul
bcell
respons
qualiti
antibodi
respons
term
vitro
protect
challeng
await
subsequ
studi
pgem
genbank
access
number
contain
sequenc
encod
newcastl
diseas
viru
ndv
transmembran
tm
cytoplasm
domain
cd
follow
sequenc
encod
translocationdefici
form
sellman
et
al
fragment
b
anthraci
pa
anthrax
pa
genbank
access
number
welko
et
al
gene
optim
human
codon
usag
ensur
high
express
level
sequenc
synthes
nontempl
pcr
insert
pgemt
vector
promega
inc
xbai
site
follow
pcr
reaction
perform
use
vent
polymeras
biolab
inc
primer
list
tabl
see
supplementari
materi
pcramplifi
pgem
use
primer
rv
vector
pspbn
morimoto
et
al
pcr
product
digest
bsiwi
nhei
ligat
result
plasmid
construct
plasmid
encod
flank
rv
g
signal
sequenc
ss
cd
tm
ntermin
amino
acid
rv
g
includ
rv
ss
aa
pcr
amplifi
ptitg
mcgettigan
et
al
use
primer
second
pcr
reaction
sequenc
encod
rv
g
tm
cd
amplifi
ptitg
use
primer
product
digest
spei
ligat
base
pair
bp
product
digest
xbai
psti
clone
xbaiand
pstidigest
pbsskii
stratagen
inc
result
plasmid
design
pbsst
sequenc
pcramplifi
pgem
use
primer
digest
spei
hpai
clone
speiand
hpaicleav
pbsst
result
plasmid
design
digest
bsiwi
xbai
clone
pspbn
yield
anthrax
pa
amplifi
pgem
use
primer
digest
avrii
hpai
clone
pbsst
yield
gener
g
chimer
glycoprotein
contain
differ
portion
rv
g
ed
see
fig
seri
rv
g
ed
fragment
amplifi
ptitg
use
revers
primer
forward
primer
plasmid
ptitg
pcr
product
well
plasmid
digest
styi
hpai
differ
ed
fragment
ligat
result
construct
recombin
rv
express
pspbn
digest
bsiwi
nhei
fragment
ligat
pspbn
result
recombin
virus
recov
use
publish
method
bsr
cell
infect
multipl
infect
moi
dulbecco
modifi
eagl
medium
dmem
mediatech
inc
supplement
fetal
bovin
serum
fb
incub
h
frequent
gentl
agit
cell
wash
three
time
phosphatebuff
salin
pb
optipro
medium
invitrogen
inc
ad
viru
harvest
day
postinfect
supernat
two
harvest
pool
clarifi
ultracentrifug
use
rotor
rpm
h
pellet
materi
resuspend
pb
overnight
betapropiolacton
bpl
sigma
inc
dilut
icecold
dh
ad
viru
solut
final
bpl
dilut
incub
continu
overnight
inactiv
viru
layer
sucros
gradient
pellet
ultracentrifug
describ
pellet
viru
resuspend
pb
store
aliquot
concentr
viru
standard
determin
bca
kit
pierc
inc
bsa
standard
viru
prepar
deterg
solut
final
concentr
deoxychol
mm
edta
mm
trishcl
proteas
inhibitor
sd
incub
min
place
wet
ice
immedi
prior
analysi
subsequ
lot
viru
analyz
sdspage
concentr
rel
viru
standard
determin
express
pa
viral
construct
analyz
bsr
cell
infect
moi
incub
h
express
g
chimera
analyz
bsr
cell
infect
moi
h
vaccinia
viru
express
promot
fuerst
et
al
follow
transfect
use
calcium
phosphat
stratagen
inc
h
incub
transfect
cell
wash
twice
dmem
incub
overnight
dmem
supplement
fb
cell
fix
incub
paraformaldehyd
min
room
temperatur
follow
two
wash
mm
glycin
pb
pbsglycin
intern
stain
cell
incub
triton
min
room
temperatur
follow
two
wash
pbsglycin
cell
immunostain
mous
antipa
monoclon
antibodi
oem
inc
follow
fitclabel
donkey
antimous
igg
jackson
immunoresearch
inc
fitclabel
antirv
nucleoprotein
centocor
inc
bsr
cell
transfect
bluescript
skii
stratagen
inc
describ
wash
pb
detach
plate
treatment
mm
edta
min
room
temperatur
wash
twice
fac
buffer
fb
pb
cell
incub
dilut
antipa
antibodi
fac
buffer
h
room
temperatur
wash
twice
fac
buffer
incub
dilut
fitclabel
donkey
antimous
igg
jackson
immunoresearch
inc
two
wash
fac
buffer
cell
fix
formaldehyd
caltag
fix
perm
min
room
temperatur
wash
twice
fac
buffer
analyz
facscan
beckman
coulter
xl
analyz
argon
ion
laser
bsr
cell
transfect
overnight
plasmid
describ
wash
twice
pb
incub
lysi
buffer
deoxychol
mm
edta
mm
trishcl
proteas
inhibitor
sd
min
wet
ice
lysat
purifi
viru
prepar
western
analysi
ad
proteinload
solut
final
concentr
betamercaptoethanol
heat
min
protein
separ
sd
polyacrylamid
gel
electrophoresi
sdspage
transfer
polyvinyl
difluorid
membran
osmon
inc
blot
block
lowfat
milk
powder
pb
follow
incub
either
dilut
antipa
dilut
antirv
g
cd
siler
et
al
pb
h
room
temperatur
wash
twice
pb
pbstween
blot
probe
dilut
hrpconjug
donkey
antimous
igg
jackson
immunoresearch
inc
donkey
antirabbit
igg
jackson
immunoresearch
inc
wash
twice
describ
chemiluminesc
appli
instruct
manufactur
sigma
inc
gener
rv
g
viru
purifi
describ
octyl
sigma
ad
final
concentr
materi
centrifug
h
rv
g
contain
supernat
remov
dilut
mgml
pb
store
viral
ribonucleoprotein
rnp
prepar
describ
koser
et
al
antigen
quantifi
bca
kit
accord
manufactur
protocol
pierc
recombin
pa
obtain
biodefens
emerg
infect
research
resourc
repositori
beiresourc
comparison
live
kill
vaccin
group
five
swiss
webster
mice
immun
intramuscularli
im
gastrocnemiu
inactiv
focusform
unit
ffu
live
inactiv
spbn
ffu
live
spbn
mice
boost
primari
inocul
week
first
immun
blood
sampl
obtain
week
inocul
doserespons
studi
group
three
swiss
webster
mice
immun
im
gastrocnemiu
ng
ng
ng
inactiv
ng
rv
g
ng
rpa
list
biolog
laboratori
inc
mice
boost
week
later
bled
week
inocul
second
experi
mice
immun
dose
inactiv
ng
rv
g
ng
rpa
lymphocyt
prolifer
analysi
group
four
swiss
webster
mice
either
left
unimmun
immun
im
gastrocnemiu
inactiv
day
week
postboost
mice
sacrif
spleen
harvest
anim
experi
perform
iacucapprov
protocol
anim
welfar
assur
elisa
plate
coat
ngwell
rpa
beiresourc
ngwell
rv
g
coat
buffer
mm
na
co
ph
overnight
plate
wash
four
time
pbstween
block
lowfat
milk
pb
h
room
temperatur
sera
dilut
pb
indic
figur
ad
well
incub
h
room
temperatur
wash
plate
time
pbstween
hrpconjug
donkey
antimous
igg
jackson
immunoresearch
inc
dilut
ad
per
well
incub
continu
min
plate
wash
four
time
pbstween
opd
substrat
prepar
accord
manufactur
instruct
sigma
inc
ad
incub
continu
min
room
temperatur
dark
reaction
stop
ad
h
optic
densiti
nm
determin
gammaglobulin
subclassspecif
elisa
perform
use
one
dilut
seri
prepar
three
mice
distribut
duplic
plate
assay
perform
use
secondari
antibodi
southern
biotechnolog
inc
southern
biotechnolog
inc
dilut
respect
singlecel
suspens
mous
spleen
harvest
week
postboost
prepar
homogen
passag
cell
strainer
erythrocyt
lyse
cell
wash
dilut
iscov
modifi
dmem
supplement
fc
mous
cellswel
seed
plate
cell
triplic
well
stimul
rv
g
rv
rnp
spbn
rpa
one
set
well
without
antigen
serv
medium
control
variou
time
point
cell
remov
plate
puls
thymidin
cell
harvest
h
later
onto
glass
fiber
filter
mat
use
cell
harvest
skatron
place
scintil
vial
ml
scintil
fluid
assess
radioact
scintil
counter
averag
triplic
well
calcul
count
per
minut
cpm
cpm
medium
control
subtract
antigen
